Overview

Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors

Status:
Completed
Trial end date:
2017-10-09
Target enrollment:
Participant gender:
Summary
RATIONALE: Using fluorescence imaging may determine the extent of kidney tumors and help in planning surgery. PURPOSE: This phase I trial is studying the best way to give indocyanine green (ICG) fluorescence imaging in finding tumors in patients with kidney tumors
Phase:
Phase 1
Details
Lead Sponsor:
City of Hope Medical Center
Collaborator:
National Cancer Institute (NCI)